ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 411 filers reported holding ENCOMPASS HEALTH CORP in Q4 2021. The put-call ratio across all filers is 0.28 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $764,818 | -66.5% | 11,388 | -66.2% | 0.01% | -66.7% |
| Q2 2023 | $2,282,504 | +17.3% | 33,710 | -6.3% | 0.02% | +20.0% |
| Q1 2023 | $1,946,139 | +9.7% | 35,973 | +21.3% | 0.02% | +5.3% |
| Q4 2022 | $1,773,785 | +24.0% | 29,657 | -6.3% | 0.02% | -5.0% |
| Q3 2022 | $1,431,000 | +327.2% | 31,637 | +430.1% | 0.02% | +300.0% |
| Q2 2022 | $335,000 | -38.0% | 5,968 | -27.9% | 0.01% | -16.7% |
| Q4 2021 | $540,000 | -29.1% | 8,274 | -18.5% | 0.01% | +100.0% |
| Q3 2021 | $762,000 | -31.3% | 10,148 | -28.6% | 0.00% | -78.6% |
| Q2 2021 | $1,109,000 | +228.1% | 14,215 | +244.2% | 0.01% | +250.0% |
| Q1 2021 | $338,000 | -58.3% | 4,130 | -57.8% | 0.00% | -60.0% |
| Q4 2020 | $810,000 | -3.6% | 9,792 | -25.4% | 0.01% | -56.5% |
| Q1 2020 | $840,000 | -89.0% | 13,126 | -90.0% | 0.02% | -85.3% |
| Q1 2019 | $7,653,000 | +219.0% | 131,050 | +237.1% | 0.16% | +164.4% |
| Q4 2018 | $2,399,000 | +27.7% | 38,878 | +61.3% | 0.06% | +118.5% |
| Q3 2018 | $1,879,000 | – | 24,100 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JANA PARTNERS LLC | 2,001,897 | $150,222,000 | 11.74% |
| JET CAPITAL INVESTORS L P | 855,100 | $64,167,000 | 10.95% |
| Davide Leone & Partners Investment Co Ltd. | 735,308 | $55,178,000 | 4.23% |
| Kent Lake Capital LLC | 110,000 | $8,254,000 | 3.55% |
| REINHART PARTNERS, LLC. | 604,274 | $53,309,000 | 2.71% |
| AREX Capital Management, LP | 74,000 | $5,553,000 | 2.59% |
| RK Capital | 179,800 | $13,492,000 | 2.55% |
| Orchard Capital Management, LLC | 108,266 | $8,124,000 | 2.44% |
| BARINGTON CAPITAL GROUP, L.P. | 24,200 | $1,816,000 | 1.88% |
| Sivik Global Healthcare LLC | 100,000 | $7,504,000 | 1.79% |